Inhibitory effects of cold atmospheric plasma-activated solution on cutaneous squamous cell carcinoma
Jingfei Wang, Zhengyi Zhang, Baochen Cheng, Xinyi Zhao, Tingyi Yin, Tianji Ni, Wenqian Du, Xinyi Liu, Shuo Feng, Ke He, Jing Zhang, Yan Sun, Dehui Xu, Yan Zheng · 2026
Read Inhibitory effects of cold atmospheric plasma-activated solution on cutaneous squamous cell carcinoma by Jingfei Wang, Zhengyi Zhang, Baochen Cheng, Xinyi Zhao, Tingyi Yin, Tianji Ni, Wenqian Du, Xinyi Liu, Shuo Feng, Ke He, Jing Zhang, Yan Sun, Dehui Xu, Yan Zheng (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13612911.txt.
Description
Jingfei Wang and co-authors test a plasma-activated liquid against a common skin cancer, in a 2026 study. Cutaneous squamous cell carcinoma is frequent, and advanced cases have few gentle treatment options. The liquid is made by exposing saline or culture fluid to cold atmospheric plasma, which loads it with reactive species. Unlike direct plasma, the liquid stores well and is easy to dose.
In mice carrying human skin tumors, the liquid shrank tumor growth and weight. Treated tumors showed fewer dividing cells and no harm to body weight or organs. Protein shifts favored cell death over survival, and a spread-linked enzyme fell. In dishes, the liquid raised reactive oxygen inside cancer cells and damaged their power plants. Two cell lines confirmed the pattern. The authors present the liquid as a candidate therapy worth developing.
Catalog record
| CREATOR | Jingfei Wang, Zhengyi Zhang, Baochen Cheng, Xinyi Zhao, Tingyi Yin, Tianji Ni, Wenqian Du, Xinyi Liu, Shuo Feng, Ke He, Jing Zhang, Yan Sun, Dehui Xu, Yan Zheng |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 40 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |